1. Study of circulating IgG antibodies to peptide antigens derived from BIRC5 and MYC in cervical cancer
    Yangchun Xu et al, 2015, FEBS Open Bio CrossRef
  2. Emerging technologies for cervical cancer screening
    Chisato Hamashima, 2021, Japanese Journal of Clinical Oncology CrossRef
  3. The Role of p16/Ki-67 Immunostaining, hTERC Amplification and Fibronectin in Predicting Cervical Cancer Progression: A Systematic Review
    Septimiu Toader Voidăzan et al, 2022, Biology CrossRef
  4. Crosstalk between cell fate and survival pathways during uterine cervical carcinoma progression: a molecular and clinical perspective
    Sudip Samadder et al, 2023, Journal of Cancer Metastasis and Treatment CrossRef
  5. c-myc Gene Copy Number Variation in Cervical Exfoliated Cells Detected on Fluorescence in situ Hybridization for Cervical Cancer Screening
    Wei-Hong Zhao et al, 2016, Gynecologic and Obstetric Investigation CrossRef
  6. Prognostic value of fluorescence in situ hybridization assay for neoplastic changes in the cervix uteri
    E. V. Golub et al, 2016, Onkologiya. Zhurnal imeni P.A.Gertsena CrossRef
  7. Disturbance of Bcl-2, Bax, Caspase-3, Ki-67 and C-myc expression in acute and subchronic exposure to benzo( a )pyrene in cervix
    Meili Gao et al, 2016, Acta Histochemica CrossRef
  8. Tacrolimus inhibits oral carcinogenesis through cell cycle control
    Yuanyuan Li et al, 2021, Biomedicine & Pharmacotherapy CrossRef
  9. Genomic amplification of HPV, h‑TERC and c‑MYC in liquid‑based cytological specimens for screening of cervical intraepithelial neoplasia and cancer
    Wenting Ji et al, 2018, Oncology Letters CrossRef
  10. Combined assessment of 3q26 amplification and promoter methylation in patients with high grade cervical lesions show age specific differences
    Josefine Beiersdorf et al, 2020, Genes, Chromosomes and Cancer CrossRef
  11. PRMT5-activated c-Myc promote bladder cancer proliferation and invasion through up-regulating NF-κB pathway
    Liang Zhang et al, 2022, Tissue and Cell CrossRef
  12. Using low-coverage whole genome sequencing technique to analyze the chromosomal copy number alterations in the exfoliative cells of cervical cancer
    Tong Ren et al, 2018, Journal of Gynecologic Oncology CrossRef
  13. Telomerase activity in cervical scrapes of women with high‑grade cervical disease: A nested case-control study
    M�nica Molano et al, 2017, Oncology Letters CrossRef
  14. The complexity of human papilloma virus in cancers: a narrative review
    Vahideh Hamidi Sofiani et al, 2023, Infectious Agents and Cancer CrossRef
  15. Polydatin Inhibits Cell Viability, Migration, and Invasion Through Suppressing the c-Myc Expression in Human Cervical Cancer
    Longchang Bai et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
  16. RETRACTED: ANRIL acts as onco-lncRNA by regulation of microRNA-24/c-Myc, MEK/ERK and Wnt/β-catenin pathway in retinoblastoma
    Feifei Yu et al, 2019, International Journal of Biological Macromolecules CrossRef